OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
Claudia Carrarini, Mirella Russo, Fedele Dono, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Prescribing in Older People
David G. Le Couteur, Sarah N. Hilmer, Nicholas Glasgow, et al.
(2025), pp. 627-712
Closed Access | Times Cited: 62

Understanding neuropsychiatric symptoms in Alzheimer’s disease: challenges and advances in diagnosis and treatment
Andrew Pless, Destany Ware, Shalini Saggu, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 44

Dementia Is More Than Memory Loss: Neuropsychiatric Symptoms of Dementia and Their Nonpharmacological and Pharmacological Management
Rajesh R. Tampi, Dilip V. Jeste
American Journal of Psychiatry (2022) Vol. 179, Iss. 8, pp. 528-543
Closed Access | Times Cited: 50

Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition
Mary Sano, Jeffrey L. Cummings, Stefanie Auer, et al.
International Psychogeriatrics (2023) Vol. 36, Iss. 4, pp. 238-250
Open Access | Times Cited: 37

Dextromethorphan/Bupropion: First Approval
Susan J. Keam
CNS Drugs (2022) Vol. 36, Iss. 11, pp. 1229-1238
Closed Access | Times Cited: 34

Symptoms and conventional treatments of Alzheimer's disease
Mehul R. Chorawala, Aayushi C. Shah, Aanshi J. Pandya, et al.
Elsevier eBooks (2024), pp. 213-234
Closed Access | Times Cited: 8

Emotional and Neuropsychiatric Disorders Associated with Alzheimer's Disease
Kenneth M. Heilman, Stephen E. Nadeau
Neurotherapeutics (2022) Vol. 19, Iss. 1, pp. 99-116
Open Access | Times Cited: 24

Selection and Progress of drugs for treating Dementia
Hany Akeel Al-Hussaniy, Ali Al‐Samydai, Maha N. Abu Hajleh, et al.
Research Journal of Pharmacy and Technology (2024), pp. 1674-1678
Closed Access | Times Cited: 5

The effect of light therapy on sleep disorders and psychobehavioral symptoms in patients with Alzheimer’s disease: A meta-analysis
Lili Zang, Xiaotong Liu, Yu Li, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0293977-e0293977
Open Access | Times Cited: 12

Scientific rationale for the use of α2A-adrenoceptor agonists in treating neuroinflammatory cognitive disorders
Amy F.T. Arnsten, Yumiko Ishizawa, Zhongcong Xie
Molecular Psychiatry (2023) Vol. 28, Iss. 11, pp. 4540-4552
Open Access | Times Cited: 11

Brain Health for All? Influence of Glycemic Control and Neuropsychiatric Symptoms in Dementia with Lewy Bodies: A Case Report and Literature Review
Patrick Stancu, Duarte Janela, Samuel Gurary, et al.
Clinical and Translational Neuroscience (2025) Vol. 9, Iss. 1, pp. 8-8
Open Access

Medications used in dementia: their management and the role of the community nurse
Karen Harrison Dening
British Journal of Community Nursing (2025) Vol. 30, Iss. 5, pp. 240-247
Closed Access

An interpretable machine learning tool for in-home monitoring of agitation episodes in people living with dementia: a proof-of-concept study
Marirena Bafaloukou, Ann‐Kathrin Schalkamp, Nan Fletcher‐Lloyd, et al.
EClinicalMedicine (2025) Vol. 80, pp. 103032-103032
Closed Access

Sundowning Syndrome in Dementia: Mechanisms, Diagnosis, and Treatment
Michalina Reimus, Mariusz Siemiński
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1158-1158
Open Access

Escitalopram for agitation in Alzheimer’s dementia: a randomized controlled phase 3 trial
Tarek K. Rajji, Sheriza Baksh, David Shade, et al.
Nature Medicine (2025)
Closed Access

A New Perspective on Agitation in Alzheimer’s Disease: A Potential Paradigm Shift
John R. Østergaard
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3370-3370
Open Access

Modernizing Medicine Through a Proof of Concept that Studies the Intersection of Robotic Exoskeletons, Computational Capacities and Dementia Care
Ritwik Raj Saxena, Arshia Khan
Communications in computer and information science (2025), pp. 373-391
Closed Access

Design insights from dementia caregivers and therapists for a therapeutic music app
Jennifer Rae Myers, Chelsea S. Brown, Esteban Roa
(2025) Vol. 2, Iss. 2
Closed Access

Chatbot-Mediated Learning For Caregiving Relatives of People With Dementia: Empirical Findings and Didactical Implications For Mulitprofessional Health Care
Daniela Schmitz, Britta Becker
Journal of Multidisciplinary Healthcare (2024) Vol. Volume 17, pp. 219-228
Open Access | Times Cited: 3

Developing a music-based digital therapeutic to help manage the neuropsychiatric symptoms of dementia
Frank Russo, Adiel Mallik, Zoe Thomson, et al.
Frontiers in Digital Health (2023) Vol. 5
Open Access | Times Cited: 8

Reduction of aggressive behaviour following hypothalamic deep brain stimulation: Involvement of 5-HT1A and testosterone
Flavia Venetucci Gouveia, Mustansir Diwan, Raquel Chacon Ruiz Martinez, et al.
Neurobiology of Disease (2023) Vol. 183, pp. 106179-106179
Open Access | Times Cited: 8

Specific agitation behaviours in dementia differentially contribute to aspects of caregiver burden
Karlee Patrick, John Gunstad, John T. Martin, et al.
Psychogeriatrics (2022) Vol. 22, Iss. 5, pp. 688-698
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top